There Have been no adverse events or variations from baseline in serologic scientific tests and essential signals in any on the participants. The treatment method's agony-relieving effects had been verified via common, twelve-7 days follow-ups, confirming the safety and effectiveness of BTX-A on Continual ON and suggesting that this method https://derma-solution.com/